International Research Journal of Innovations in Engineering and Technology - IRJIET International Open Access, Monthly, Peer Reviewed, Reputed Journal ISSN (online): 2581-3048

Impact Factor (2025): 6.9

DOI Prefix: 10.47001/IRJIET

Forecasting Covid-19 Mortality in Chile

Dr. Smartson. P. NYONIZICHIRe Project, University of Zimbabwe, Harare, ZimbabweMr. Thabani NYONISAGIT Innovation Center, Harare, ZimbabweMr. Tatenda. A. CHIHOHOIndependent Health Economist, Harare, Zimbabwe

Vol 5 No 6 (2021): Volume 5, Issue 6, June 2021 | Pages: 169-175

International Research Journal of Innovations in Engineering and Technology

OPEN ACCESS | Research Article | Published Date: 08-07-2021

doi Logo doi.org/10.47001/IRJIET/2021.506032

pdf iconFull Text PDF
Abstract

In this study, the ANN approach was applied to analyze COVID-19 deaths in Chile. The employed data covers the period 1January 2020 to 20 April 2021 and the out-of-sample period ranges over the period 21 April to 31 August 2021. The residuals and forecast evaluation criteria (Error, MSE and MAE) of the applied model indicate that the model is quite stable. The results of the study indicate that daily COVID-19 deaths in Chile are likely to be between 0 and 150 per day over the out-of-sample period. Therefore there is need for the government of Chile to ensure adherence to safety guidelines while continuing to create awareness about the COVID-19 pandemic and speed up COVID-19 vaccination.

Keywords

ANN, COVID-19, Forecasting


Citation of this Article

Dr. Smartson. P. NYONI, Mr. Thabani NYONI, Mr. Tatenda. A. CHIHOHO, “Forecasting Covid-19 Mortality in Chile” Published in International Research Journal of Innovations in Engineering and Technology - IRJIET, Volume 5, Issue 6, pp 169-175, June 2021. Article DOI https://doi.org/10.47001/IRJIET/2021.506032

Licence Copyright (c) 2026 International Research Journal of Innovations in Engineering and Technology creative common licence This work is licensed under Creative common Attribution Non Commercial 4.0 Internation Licence
References
  1. Asahi K., Undurraga EA., Valdes R., & Wagner R (2021). The effect of COVID-19 on the economy: evidence from an early adopter of localized lockdowns. J Glob Health. 2021; in press.
  2. De Souza WM., Buss LF., CandidoDdS., Carrera J-P., Li S., Zarebski AE (2020). Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil. Nat Hum Behav, 4(8):856–65. https:// doi.org/10.1038/s41562-020-0928-4 PMID: 32737472
  3. Eric Toner (2021). Potential Solutions to the COVID-19 Oxygen Crisis in the United States , Johns Hopkins Center for Health Security, centerforhealthsecurity.org, pp 1-3
  4. Flaxman S., Mishra S., Gandy A., Unwin HJ T., Mellan TA., Coupland H (2020). Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020; 584(7820):257–61. https:// doi.org/10.1038/s41586-020-2405-7 PMID: 32512579
  5. Goic M., Bozanic-Leal MS., Badal M., & Basso LJ (2021) COVID-19: Short-term forecast of ICU beds in times of crisis. PLoS ONE 16(1): e0245272. https://doi.org/10.1371/journal. pone.0245272
  6. Holshue M L., DeBolt C., Lindquist S., Lofy K H., Wiesman J, Bruce (2020). First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020; 382(10):929–36. https://doi.org/10.1056/ NEJMoa2001191 PMID: 32004427
  7. Li Y., Campbell H., Kulkarni D., Harpur A., Nundy M., Wang X (2020). The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries. Lancet Infect Dis. 2020. Epub October 22. https://doi.org/10.1016/S1473-3099(20)30785-4.
  8. PGT., Whittaker C., Watson OJ., Baguelin M., Winskill P., Hamlet A, et al. The impact of COVID19 and strategies for mitigation and suppression in low- and middle-income countries. Science (New York, NY). 2020; 369(6502):413–22. https://doi.org/10.1126/science.abc0035 PMID: 32532802
  9. Spiteri G., Fielding J., Diercke M., Campese C., Enouf V., Gaymard A (2020). First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Euro Surveill, 25(9):2000178. Doi: 10.2807/1560-7917.ES.2020.25.9.2000178. PMID: 32156327.
  10. Tang. B et al (2020).  An updated estimation of the risk of transmission of the novel coronavirus (2019-nCoV). Infectious Disease Modelling 5, 248–255.
  11. Tang. B et al (2020). Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions. J. Clinical Med. 9, 462.
  12. Wang D et al (2020).  Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 323, 1061–1069.
  13. Wang H et al (2020). Phase-adjusted estimation of the number of coronavirus disease 2019 cases in Wuhan, China. Cell Discovery 6, 76.
  14. Wang. W et al (2020). Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J. Med. Virology 92, 441–447.
  15. WHO (2020). Situation Reports Coronavirus World Health Organization2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports

Copyright @ 2026 IRJIET. All Right Reserved.

Licensed underCreative Commons Attribution 4.0 International License.